Medical Developments International has released a press release.
Penthrox Marketing Authorisation Application in Russia
Filed with ASX ·
Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19Read the transcript of Medical Developments International (ASX:MVP) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Medical Developments International Limited on 6ix
Story so far
Earlier from Medical Developments International
- Penthrox IND approved in China
- CEO Roadshow Presentation
- Chairmans Address to Shareholders
- MVP signs new Manufacturing Development Project with CSIRO
- Penthrox approved in EUSEM guidelines
Later from Medical Developments International
- FY20 HY Report and Accounts
- MVP announces leadership change
- COVID-19 Impact on MVP
- Penthrox is approved in Thailand
- Penthrox approved - Netherlands and Bosnia and Herzegovina
Follow Medical Developments International into a list and get an email when it puts out news.
Follow Medical Developments International